apps
UCB presentation highlights impacts of epilepsy on daily life
The data underlines the consequences of disrupted sleep for patients and caregivers
EpilepsyMeds receives Highly Commended recognition at Excellence in Healthcare Partnership Awards 2026
EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing epilepsy care.
The digital reality check: How pharma measures up in 2025
Download your copy of our latest pharma white paper, exploring the latest digital trends, challenges and opportunities in pharma.
UCB’s Fintepla shows positives results for Lennox-Gastaut syndrome
The study demonstrated a sustained reduction in seizures for patients
Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App
Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.
Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App
Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in epilepsy care. The...
UCB shares promising results for fenfluramine in ultra-rare form of epilepsy
CDKL5 deficiency disorder occurs in approximately one in 40,000 to 60,000 live births
PMGroup and Visions4Health launch Excellence in Healthcare Partnerships Awards
The programme was unveiled at this year’s NHS ConfedExpo in Manchester
Establishing Remote Work Norms – Building Company Culture Virtually
Ready to redefine remote work in pharma? The second step is establishing clear norms, processes, and expectations that resonate with your team. Dive into our series for more tips on...
Driving behaviour change for positive patient outcomes in pharma
Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.
Takeda shares late-stage results for investigational soticlestat in rare epileptic disorders
Dravet syndrome and Lennox-Gastaut syndrome are drug-resistant to many anti-seizure medications
Disconnected pharma: Navigating digital challenges and priorities in 2024
We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...